Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C009505 |
4,4'-diaminodiphenylmethane |
4,4'-diaminodiphenylmethane results in decreased expression of EPHA1 mRNA | decreases expression | 18648102
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of EPHA1 mRNA | affects expression | 17562736
|
D001149 |
Arsenates |
[Atrazine co-treated with Arsenates] results in increased expression of EPHA1 mRNA | affects cotreatment|increases expression | 18585445
|
D001280 |
Atrazine |
[Atrazine co-treated with Arsenates] results in increased expression of EPHA1 mRNA | affects cotreatment|increases expression | 18585445
|
C004742 |
daidzein |
[Genistein co-treated with daidzein co-treated with glycitein] results in increased expression of EPHA1 mRNA | affects cotreatment|increases expression | 16963248
|
C014347 |
decitabine |
decitabine results in decreased methylation of EPHA1 promoter | decreases methylation | 19277044
|
C014347 |
decitabine |
decitabine results in increased expression of EPHA1 mRNA | increases expression | 19277044
|
C014347 |
decitabine |
decitabine results in increased expression of EPHA1 protein | increases expression | 19277044
|
D015073 |
2-Acetylaminofluorene |
2-Acetylaminofluorene results in increased expression of EPHA1 mRNA | increases expression | 17317680
|
D019833 |
Genistein |
[Genistein co-treated with daidzein co-treated with glycitein] results in increased expression of EPHA1 mRNA | affects cotreatment|increases expression | 16963248
|
C086566 |
glycitein |
[Genistein co-treated with daidzein co-treated with glycitein] results in increased expression of EPHA1 mRNA | affects cotreatment|increases expression | 16963248
|
D008769 |
Methylnitronitrosoguanidine |
Methylnitronitrosoguanidine results in increased expression of EPHA1 mRNA | increases expression | 12634122
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of EPHA1 mRNA | affects binding|decreases expression|increases activity | 19710929
|
C006253 |
pirinixic acid |
pirinixic acid results in decreased expression of EPHA1 mRNA | decreases expression | 18445702
|
C017947 |
sodium arsenite |
sodium arsenite results in increased expression of EPHA1 mRNA | increases expression | 12760830
|
D014415 |
Tunicamycin |
Tunicamycin results in increased expression of EPHA1 mRNA | increases expression | 17127020
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.20 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
daidzein |
5.01 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Genistein |
5.01 | 11473722 |
MESH:D000236 |
Adenoma |
|
2-Acetylaminofluorene |
7.15 | 10737359 |
MESH:D000236 |
Adenoma |
|
4,4'-diaminodiphenylmethane |
7.15 | 3712494 |
MESH:D002759 |
Adenoma, Bile Duct |
|
2-Acetylaminofluorene |
6.14 | 6705139 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
3.60 | 16434500 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.83 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
5.04 | 16712894 17306315 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Atrazine |
4.34 | 11874814 |
MESH:D000544 |
Alzheimer Disease |
marker/mechanism |
|
| 21460841 21460840 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.98 | 10982225 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.41 | 18445737 |
MESH:D001660 |
Biliary Tract Diseases |
|
4,4'-diaminodiphenylmethane |
5.15 | 1440618 11289319 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
3.23 | 19483382 |
MESH:D001943 |
Breast Neoplasms |
|
decitabine |
2.39 | 19208741 18320071 |
MESH:D001943 |
Breast Neoplasms |
|
Genistein |
2.39 | 16541309 17200150 16873071 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2-Acetylaminofluorene |
9.02 | 3084413 10737359 17761372 3581430 6705139 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
4,4'-diaminodiphenylmethane |
9.02 | 3581430 7296757 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
9.02 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Genistein |
9.02 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
9.02 | 17306315 15276417 16507464 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
4,4'-diaminodiphenylmethane |
2.71 | 7296757 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
decitabine |
4.87 | 19215824 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
4.87 | 18572023 |
MESH:D002318 |
Cardiovascular Diseases |
|
daidzein |
7.98 | 16332659 |
MESH:D002318 |
Cardiovascular Diseases |
|
Genistein |
7.98 | 16332659 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
2.63 | 10977129 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
4,4'-diaminodiphenylmethane |
11.70 | 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Methylnitronitrosoguanidine |
11.70 | 2727394 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
11.70 | 20056578 19524636 |
MESH:D002779 |
Cholestasis |
|
4,4'-diaminodiphenylmethane |
8.04 | 9022650 19486331 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
8.04 | 19176532 |
MESH:D003110 |
Colonic Neoplasms |
|
decitabine |
3.93 | 17616700 |
MESH:D003110 |
Colonic Neoplasms |
|
Genistein |
3.93 | 17182828 |
MESH:D015179 |
Colorectal Neoplasms |
marker/mechanism |
|
| 19277044 |
MESH:D015179 |
Colorectal Neoplasms |
|
decitabine |
2.10 | 18981723 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
4,4'-diaminodiphenylmethane |
2.90 | 2524372 12868966 11906362 8156756 14531868 18759878 8970840 11298694 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.46 | 18249437 |
MESH:D003877 |
Dermatitis, Contact |
|
4,4'-diaminodiphenylmethane |
3.58 | 3621924 2952479 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
daidzein |
5.04 | 16647724 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Genistein |
5.04 | 16647724 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4,4'-diaminodiphenylmethane |
3.78 | 16192314 8291058 7440962 9328219 18692083 9022650 18289764 11289319 9653073 18648102 1440618 6679447 6482804 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
3.78 | 16485898 12705907 19370779 2444490 19420014 16177239 19164858 11421492 17562736 16781746 10663392 16109766 16393943 16081117 12392966 16227642 12594235 11287661 11529661 15968718 12153990 12958197 18713872 17522070 10774834 17906064 19923254 19085960 12540782 10915739 11461765 11834606 19416960 14725611 11739529 19739265 11743745 15619225 14550746 14986274 18071297 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
4.23 | 19426721 |
MESH:D004487 |
Edema |
|
pirinixic acid |
2.56 | 12083418 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
decitabine |
5.25 | 19294695 |
MESH:D004714 |
Endometrial Hyperplasia |
|
Genistein |
4.71 | 16402032 |
MESH:D016889 |
Endometrial Neoplasms |
|
daidzein |
8.17 | 11473722 |
MESH:D016889 |
Endometrial Neoplasms |
|
Genistein |
8.17 | 11473722 |
MESH:D007172 |
Erectile Dysfunction |
|
daidzein |
5.11 | 14972507 |
MESH:D004938 |
Esophageal Neoplasms |
|
4,4'-diaminodiphenylmethane |
2.12 | 3581430 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
2.85 | 19236843 20131406 |
MESH:D005350 |
Fibroma |
|
4,4'-diaminodiphenylmethane |
5.15 | 6705139 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.81 | 16983495 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.80 | 16452187 |
MESH:D005909 |
Glioblastoma |
|
Genistein |
3.31 | 16598420 |
MESH:D006042 |
Goiter |
|
4,4'-diaminodiphenylmethane |
4.12 | 7505956 |
MESH:D006258 |
Head and Neck Neoplasms |
|
decitabine |
3.54 | 19215824 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.58 | 20558911 |
MESH:D006390 |
Hemangioendothelioma |
|
2-Acetylaminofluorene |
5.45 | 6705139 |
MESH:D006394 |
Hemangiosarcoma |
|
2-Acetylaminofluorene |
4.49 | 6705139 |
MESH:D006505 |
Hepatitis |
|
4,4'-diaminodiphenylmethane |
3.61 | 6705139 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
3.10 | 16221962 19772884 18467677 19176532 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
3.22 | 12676792 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
2.76 | 16870215 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.26 | 20558911 |
MESH:D006965 |
Hyperplasia |
|
4,4'-diaminodiphenylmethane |
4.04 | 15034207 |
MESH:D006973 |
Hypertension |
|
daidzein |
3.70 | 17169123 |
MESH:D007248 |
Infertility, Male |
|
Atrazine |
11.71 | 12948887 |
MESH:D007248 |
Infertility, Male |
|
decitabine |
11.71 | 17581917 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
11.71 | 15346721 12646999 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.68 | 16306350 |
MESH:D007565 |
Jaundice |
|
4,4'-diaminodiphenylmethane |
5.15 | 8074119 9022650 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
6.11 | 15629191 12587719 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
6.11 | 20008137 |
MESH:D007680 |
Kidney Neoplasms |
|
4,4'-diaminodiphenylmethane |
3.03 | 6582329 |
MESH:D007938 |
Leukemia |
|
decitabine |
6.65 | 18980019 19235587 |
MESH:D007938 |
Leukemia |
|
Genistein |
6.65 | 17468513 18980019 |
MESH:D007951 |
Leukemia, Myeloid |
|
decitabine |
4.08 | 19117987 17236224 18454857 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
decitabine |
2.39 | 18206229 19010910 19387464 17679729 18704418 18460780 |
MESH:D015477 |
Leukemia, Myelomonocytic, Chronic |
|
decitabine |
5.60 | 18055864 |
MESH:D008105 |
Liver Cirrhosis, Biliary |
|
4,4'-diaminodiphenylmethane |
3.24 | 9327722 15034207 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Genistein |
2.46 | 17823541 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
2.46 | 15474484 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
1.65 | 12587719 12969438 16610002 19784758 11587558 16611625 19014921 19460945 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
3.31 | 16871587 17185352 |
MESH:D008113 |
Liver Neoplasms |
|
2-Acetylaminofluorene |
7.71 | 11376686 16273603 14678523 10672840 18001218 10737359 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
7.71 | 20007298 15890375 16377806 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
7.71 | 16712894 15276417 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2-Acetylaminofluorene |
6.41 | 534488 6150874 1399818 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
4,4'-diaminodiphenylmethane |
6.41 | 598648 6587162 3712494 1399818 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
3.22 | 19095001 |
MESH:D008175 |
Lung Neoplasms |
|
2-Acetylaminofluorene |
2.84 | 11376686 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
2.84 | 15276417 17077188 19931552 17306315 16712894 |
MESH:D008223 |
Lymphoma |
|
decitabine |
3.47 | 19470736 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Genistein |
2.99 | 14578162 12929590 |
MESH:D008545 |
Melanoma |
|
decitabine |
3.49 | 16505122 17785578 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
3.49 | 16487513 19082730 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.67 | 19513568 |
MESH:D008654 |
Mesothelioma |
|
Atrazine |
3.56 | 1916698 |
MESH:D053842 |
Microsatellite Instability |
|
Methylnitronitrosoguanidine |
6.01 | 17671175 |
MESH:D009101 |
Multiple Myeloma |
|
decitabine |
3.40 | 18172295 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.61 | 16239165 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
decitabine |
3.43 | 19157545 16882708 18608210 19010910 |
MESH:D009203 |
Myocardial Infarction |
|
Genistein |
5.78 | 17141266 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
5.78 | 19151258 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Genistein |
8.60 | 17141266 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
8.60 | 16411023 |
MESH:D009362 |
Neoplasm Metastasis |
|
4,4'-diaminodiphenylmethane |
2.50 | 3581430 |
MESH:D009369 |
Neoplasms |
|
decitabine |
8.50 | 17925555 19116145 19470736 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
8.50 | 17405874 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
8.50 | 11559025 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
3.77 | 20056578 |
MESH:D009421 |
Nervous System Malformations |
|
Genistein |
4.13 | 16427766 |
MESH:D009436 |
Neural Tube Defects |
|
4,4'-diaminodiphenylmethane |
7.43 | 6679447 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
7.43 | 12854658 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
2.94 | 18514411 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.83 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
4,4'-diaminodiphenylmethane |
3.50 | 6482804 4026338 |
MESH:D009902 |
Optic Neuritis |
|
4,4'-diaminodiphenylmethane |
5.15 | 3988306 |
MESH:D010024 |
Osteoporosis |
|
Genistein |
3.30 | 19401787 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Genistein |
4.17 | 16169203 |
MESH:D010051 |
Ovarian Neoplasms |
|
decitabine |
8.11 | 19331143 19259094 |
MESH:D010051 |
Ovarian Neoplasms |
|
Genistein |
8.11 | 19005980 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
8.11 | 15276417 17306315 |
MESH:D010146 |
Pain |
|
Acetaminophen |
2.46 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
decitabine |
2.79 | 19294695 |
MESH:D010212 |
Papilloma |
|
4,4'-diaminodiphenylmethane |
3.59 | 7296757 |
MESH:D010300 |
Parkinson Disease |
|
Atrazine |
3.30 | 17218051 |
MESH:D010787 |
Photosensitivity Disorders |
|
4,4'-diaminodiphenylmethane |
4.60 | 6228378 |
MESH:D055728 |
Primary Myelofibrosis |
|
decitabine |
4.83 | 17616702 |
MESH:D011471 |
Prostatic Neoplasms |
|
Genistein |
3.35 | 16925846 15378649 15256057 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
3.35 | 16039940 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.42 | 19058328 |
MESH:D012135 |
Respiratory Sounds |
|
Atrazine |
4.62 | 11874814 |
MESH:D012162 |
Retinal Degeneration |
|
4,4'-diaminodiphenylmethane |
3.43 | 3692021 |
MESH:D012208 |
Rhabdomyosarcoma |
|
decitabine |
4.49 | 19155313 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
2.73 | 18572023 19524636 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.86 | 12854658 |
MESH:D013274 |
Stomach Neoplasms |
|
decitabine |
2.10 | 19037991 |
MESH:D013964 |
Thyroid Neoplasms |
|
4,4'-diaminodiphenylmethane |
7.45 | 6582329 3712494 1399818 6587162 7505956 |
MESH:D013964 |
Thyroid Neoplasms |
|
decitabine |
7.45 | 17967635 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2-Acetylaminofluorene |
12.24 | 1399818 15867355 15289314 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
4,4'-diaminodiphenylmethane |
12.24 | 8074119 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
decitabine |
12.24 | 19087683 17616700 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
12.24 | 16452187 16712894 11723127 17306315 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
3.06 | 10982225 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
3.84 | 11813266 |
MESH:D014604 |
Uveal Neoplasms |
|
decitabine |
5.05 | 17785578 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.54 | 17056641 |